Spinning out of control...

Here's the latest from Wealthy Retirement... ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

AN OXFORD CLUB PUBLICATION

(Clicking the image above will opt you in to free updates about the Commodities Supercycle Summit, a free subscription to the Wealthy Retirement e-letter, and offers from us and our affiliates that we think might interest you. You can unsubscribe at any time. Privacy Policy.)

– ON THE AIR –

Inflation is running rampant... Banks are failing... And America's debt is shooting higher and higher. While many people are either ignoring these major trends or holding on to cash... The smart money is moving into one of the few asset classes that outperform during times like these... Commodities. Check out Chief Income Strategist Marc Lichtenfeld's latest video here. WATCH NOW

– THE VALUE METER –

Very few companies' stock prices benefited more from the pandemic than this exercise equipment manufacturer. Over the nine months that followed the COVID-19 outbreak in the U.S., its share price jumped 738%. But that was the peak. From there, everything has gone speeding downhill. From the January 2021 top at $167, the stock price has now collapsed to below $8 - an unfathomable 95% drop! Ouch! And even still, The Value Meter rates its shares as "Extremely Overvalued." Find out who's rolling into dangerous territory... AVOID THIS STOCK

– OVERHEARD –

"I look forward to Marc's suggestions and guidance. He really provides me with confidence that what should be done is realistic and without self-interest on his part." - Wealthy Retirement Reader M.P. Have an experience that you'd like to share with the team at Wealthy Retirement? Click here to send us a message.

SPONSORED 66,000% upside on tiny biotech? The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price. Get all the details here >>>

– TOP ARTICLES –

THE SWEET SIDE OF RISING SUGAR PRICES Sugar prices are so hot right now that they're turning into caramel. But the sweet side of commodities investing is that it gives us a chance to profit. Read more here. WHEN (AND HOW) TO TEACH YOUR KIDS ABOUT MONEY Having "the talk" is never easy - but most people would choose that over the money conversation. Read more here. THE HEADLINES ARE BEARISH... HERE'S WHAT THEY'RE MISSING Here's where you need to be careful... Read more here.

– MORE FROM OUR NETWORK OF EXPERTS –

Is It Time to Think Small? >> Don't Be Fooled By the Debt Ceiling Fight >> Buy the PEP Dip Now >>

Facebook Twitter

SPONSORED The Best Business You've Never Heard Of Imagine profiting every time a prescription is filled anywhere around the world. Healthcare sector expert Marc Lichtenfeld has discovered a company that does just that... And he believes it could make you 3,000% richer by this time next year. Access the details here before midnight ET tonight for maximum profit potential.

You are receiving this email because you subscribed to Wealthy Retirement. Wealthy Retirement is published by The Oxford Club. Questions? Check out our FAQs. Trying to reach us? Contact us here. Please do not reply to this email as it goes to an unmonitored inbox. Privacy Policy | Whitelist Wealthy Retirement | Unsubscribe © 2023 The Oxford Club, LLC All Rights Reserved The Oxford Club | 105 West Monument Street | Baltimore, MD 21201 North America: 877.808.9795 | International: 443.353.4621 Oxfordclub.com

Nothing published by The Oxford Club should be considered personalized investment advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed personalized investment advice. We allow the editors of our publications to recommend securities that they own themselves. However, our policy prohibits editors from exiting a personal trade while the recommendation to subscribers is open. In no circumstance may an editor sell a security before subscribers have a fair opportunity to exit. The length of time an editor must wait after subscribers have been advised to exit a play depends on the type of publication. All other employees and agents must wait 24 hours after publication before trading on a recommendation. Any investments recommended by The Oxford Club should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. The information found on this website may only be used pursuant to the membership or subscription agreement and any reproduction, copying or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of The Oxford Club, LLC, 105 West Monument Street, Baltimore, MD 21201.